138 related articles for article (PubMed ID: 38182386)
1. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers.
Zheng H; Su N; Yan G; Li M; Chu H; Zhang J; Li B; Zhao J; Wang J; Gao M; Zhang X
Anal Chim Acta; 2024 Jan; 1287():342109. PubMed ID: 38182386
[TBL] [Abstract][Full Text] [Related]
2. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
Whiteside TL
Biochem Soc Trans; 2013 Feb; 41(1):245-51. PubMed ID: 23356291
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis.
Chen H; Chengalvala V; Hu H; Sun D
Acta Pharm Sin B; 2021 Aug; 11(8):2136-2149. PubMed ID: 34522581
[TBL] [Abstract][Full Text] [Related]
5. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
6. Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer.
Verdi J; Ketabchi N; Noorbakhsh N; Saleh M; Ebrahimi-Barough S; Seyhoun I; Kavianpour M
Curr Stem Cell Res Ther; 2022; 17(1):91-102. PubMed ID: 34161212
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
[TBL] [Abstract][Full Text] [Related]
8. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
[TBL] [Abstract][Full Text] [Related]
9. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
10. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
12. One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticles.
Zhang M; Xia L; Mei W; Zou Q; Liu H; Wang H; Zou L; Wang Q; Yang X; Wang K
Anal Chim Acta; 2023 May; 1254():341130. PubMed ID: 37005015
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets.
Liang B; Hu X; Ding Y; Liu M
J Cell Physiol; 2021 Jun; 236(6):4138-4151. PubMed ID: 33275291
[TBL] [Abstract][Full Text] [Related]
14. The Role of Tumor-Derived Exosomes in the Abscopal Effect and Immunotherapy.
Shan Z; Wang H; Zhang Y; Min W
Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33922480
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.
Hosseini M; Baghaei K; Amani D; Ebtekar M
Daru; 2021 Dec; 29(2):267-278. PubMed ID: 34405380
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomes: immune properties and clinical application in lung cancer.
Wu J; Li S; Zhang P
Cancer Drug Resist; 2022; 5(1):102-113. PubMed ID: 35582534
[TBL] [Abstract][Full Text] [Related]
17. A colorimetric and photothermal dual-mode biosensing platform based on nanozyme-functionalized flower-like DNA structures for tumor-derived exosome detection.
Zhang X; Zhu X; Li Y; Hai X; Bi S
Talanta; 2023 Jun; 258():124456. PubMed ID: 36940568
[TBL] [Abstract][Full Text] [Related]
18. Exosomes in Cancer: Circulating Immune-Related Biomarkers.
Głuszko A; Szczepański MJ; Ludwig N; Mirza SM; Olejarz W
Biomed Res Int; 2019; 2019():1628029. PubMed ID: 31915681
[TBL] [Abstract][Full Text] [Related]
19. TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice.
Yildirim M; Yildirim TC; Turay N; Bildik T; Ibibik B; Evcili I; Ersan PG; Tokat UM; Sahin O; Gursel I
Immunol Lett; 2021 Nov; 239():32-41. PubMed ID: 34418488
[TBL] [Abstract][Full Text] [Related]
20. Target-induced proximity ligation triggers recombinase polymerase amplification and transcription-mediated amplification to detect tumor-derived exosomes in nasopharyngeal carcinoma with high sensitivity.
Liu W; Li J; Wu Y; Xing S; Lai Y; Zhang G
Biosens Bioelectron; 2018 Apr; 102():204-210. PubMed ID: 29145073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]